The U.S. Food and Drug Administration has approved the first drug developed specifically to reduce excessive sweating, a common condition that can cause anxiety.
Dermira Inc. said Friday its Qbrexza was approved for excessive underarm sweating. The drug is inside a cloth wiped over the skin daily to block sweat glands from activating.
Dermira refused to disclose the price. Qbrexza will be available in October.
An estimated 15.3 million Americans have some form of excessive sweating, but only 1 in 4 get treatment. Current treatment options include Botox injections, surgery and off-label use of drugs that block the body’s chemical messengers.
Dermira said in one study, 53 percent of patients reported Qbrexza reduced sweat production by roughly half, versus 28 percent in a comparison group using a nonmedicated cloth.
Send questions/comments to the editors.
Success. Please wait for the page to reload. If the page does not reload within 5 seconds, please refresh the page.
Enter your email and password to access comments.
Hi, to comment on stories you must . This profile is in addition to your subscription and website login.
Already have a commenting profile? .
Invalid username/password.
Please check your email to confirm and complete your registration.
Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.
Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.